Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis

It remains to be seen whether S-1 can be a replacement for infusional fluorouracil (5-FU) for advanced gastric cancer (AGC). The aim of this study was to compare the efficacy and safety of S-1 with 5-FU in AGC. PubMed and Cochrane Library were searched. Randomized controlled trials and meta-analyses...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Chen, Xiao-Dong, He, Fu-Qian, Chen, Mi, Tang, Ling-Chao, Tang, Xiao-Li
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2016
Témata:
5700
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998483/
https://ncbi.nlm.nih.gov/pubmed/27310997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003916
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky